Rozemarijn Snoek1, Marijn F Stokman1, Klaske D Lichtenbelt1, Theodora C van Tilborg2, Cindy E Simcox2, Aimée D C Paulussen3, Jos C M F Dreesen3, Franka van Reekum4, A Titia Lely5, Nine V A M Knoers1,6, Christine E M de Die-Smulders3, Albertien M van Eerde7. 1. Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Department of Reproductive Medicine and Gynaecology, University Medical Center Utrecht, Utrecht, The Netherlands. 3. Department of Clinical Genetics, Maastricht University Medical Center+, Maastricht, The Netherlands. 4. Department of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands. 5. Department of Obstetrics, University Medical Center Utrecht, Utrecht, The Netherlands. 6. Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands. 7. Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands a.vaneerde@umcutrecht.nl.
Abstract
BACKGROUND AND OBJECTIVES: A genetic cause can be identified for an increasing number of pediatric and adult-onset kidney diseases. Preimplantation genetic testing (formerly known as preimplantation genetic diagnostics) is a reproductive technology that helps prospective parents to prevent passing on (a) disease-causing mutation(s) to their offspring. Here, we provide a clinical overview of 25 years of preimplantation genetic testing for monogenic kidney disease in The Netherlands. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This is a retrospective cohort study of couples counseled on preimplantation genetic testing for monogenic kidney disease in the national preimplantation genetic testing expert center (Maastricht University Medical Center+) from January 1995 to June 2019. Statistical analysis was performed through chi-squared tests. RESULTS: In total, 98 couples were counseled regarding preimplantation genetic testing, of whom 53% opted for preimplantation genetic testing. The most frequent indications for referral were autosomal dominant polycystic kidney disease (38%), Alport syndrome (26%), and autosomal recessive polycystic kidney disease (9%). Of couples with at least one preimplantation genetic testing cycle with oocyte retrieval, 65% experienced one or more live births of an unaffected child. Of couples counseled, 38% declined preimplantation genetic testing for various personal and technical reasons. CONCLUSIONS: Referrals, including for adult-onset disease, have increased steadily over the past decade. Though some couples decline preimplantation genetic testing, in the couples who proceed with at least one preimplantation genetic testing cycle, almost two thirds experienced at least one live birth rate.
BACKGROUND AND OBJECTIVES: A genetic cause can be identified for an increasing number of pediatric and adult-onset kidney diseases. Preimplantation genetic testing (formerly known as preimplantation genetic diagnostics) is a reproductive technology that helps prospective parents to prevent passing on (a) disease-causing mutation(s) to their offspring. Here, we provide a clinical overview of 25 years of preimplantation genetic testing for monogenic kidney disease in The Netherlands. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This is a retrospective cohort study of couples counseled on preimplantation genetic testing for monogenic kidney disease in the national preimplantation genetic testing expert center (Maastricht University Medical Center+) from January 1995 to June 2019. Statistical analysis was performed through chi-squared tests. RESULTS: In total, 98 couples were counseled regarding preimplantation genetic testing, of whom 53% opted for preimplantation genetic testing. The most frequent indications for referral were autosomal dominant polycystic kidney disease (38%), Alport syndrome (26%), and autosomal recessive polycystic kidney disease (9%). Of couples with at least one preimplantation genetic testing cycle with oocyte retrieval, 65% experienced one or more live births of an unaffected child. Of couples counseled, 38% declined preimplantation genetic testing for various personal and technical reasons. CONCLUSIONS: Referrals, including for adult-onset disease, have increased steadily over the past decade. Though some couples decline preimplantation genetic testing, in the couples who proceed with at least one preimplantation genetic testing cycle, almost two thirds experienced at least one live birth rate.
Authors: Oliver Gross; Christoph Licht; Hans J Anders; Bernd Hoppe; Bodo Beck; Burkhard Tönshoff; Britta Höcker; Simone Wygoda; Jochen H H Ehrich; Lars Pape; Martin Konrad; Wolfgang Rascher; Jörg Dötsch; Dirk E Müller-Wiefel; Peter Hoyer; Bertrand Knebelmann; Yves Pirson; Jean-Pierre Grunfeld; Patrick Niaudet; Pierre Cochat; Laurence Heidet; Said Lebbah; Roser Torra; Tim Friede; Katharina Lange; Gerhard A Müller; Manfred Weber Journal: Kidney Int Date: 2011-12-14 Impact factor: 10.612
Authors: V Berckmoes; P Verdyck; P De Becker; A De Vos; G Verheyen; P Van der Niepen; W Verpoest; I Liebaers; M Bonduelle; K Keymolen; M De Rycke Journal: Hum Reprod Date: 2019-05-01 Impact factor: 6.918
Authors: E Vanneste; C Melotte; S Debrock; T D'Hooghe; H Brems; J P Fryns; E Legius; J R Vermeesch Journal: Hum Reprod Date: 2009-03-10 Impact factor: 6.918
Authors: Nathan R Hill; Samuel T Fatoba; Jason L Oke; Jennifer A Hirst; Christopher A O'Callaghan; Daniel S Lasserson; F D Richard Hobbs Journal: PLoS One Date: 2016-07-06 Impact factor: 3.240
Authors: Jessica L Chaperon; Nina M Wemmer; Trudy A McKanna; Dinah M Clark; Maggie A Westemeyer; Philippe Gauthier; Yan Bai; Jessica M Coleman Journal: Am J Nephrol Date: 2021-09-02 Impact factor: 3.754